Joe Tippens: Complete Remission from Stage 4 Small Cell Lung Cancer with Widespread Metastases

Few stories in the global cancer community have sparked as much conversation, hope, and scientific curiosity as that of Joe Tippens. When I was undergoing treatment for my own stage 4 cancer, Joe’s story struck an immediate personal chord with me: just like Joe, I was prescribed Pembrolizumab (Keytruda), a modern immunotherapy that teaches the immune system to unmask cancer cells.

In 2016, Joe was diagnosed with small cell lung cancer (SCLC), one of the most aggressive and fast-moving malignancies known in oncology. By the time it was discovered, it had spread throughout his neck, liver, pancreas, bladder, and bones. Sent home with less than a one percent chance of surviving and placed on hospice, Joe achieved what his doctors called an extraordinary miracle: completely clear PET scans within months, which remain 100% cancer-free over eight years later.

The Diagnosis: Lit Up Like a Christmas Tree

In August 2016, Joe Tippens was preparing to move from Oklahoma to Switzerland for his work when an unexpected cough prompted a routine chest X-ray. The image revealed a large tumor in his left lung. Further workup at MD Anderson Cancer Center in Houston confirmed small cell lung cancer.

Despite standard chemotherapy and radiation, a full-body PET scan in January 2017 brought crushing news: the cancer had metastasized across his entire body. Tumors covered his neck, liver, pancreas, bladder, and bones from his ribs to his pelvis. His oncologist frankly told him that he had about three months to live. Joe was advised to spend his remaining days saying goodbye to his family.

The Unexpected Tip: Veterinary Oncology Research

Shortly after receiving his hospice referral, Joe received a phone call from an old college friend who was a veterinarian. The friend told him about published laboratory experiments in which a common antiparasitic compound, fenbendazole, had unexpectedly caused complete tumor regression in animal cancer research while exhibiting zero toxicity to healthy liver, kidney, or bone marrow cells.

Having nothing to lose, Joe decided to take action. He ordered the compound and built a daily supportive stack designed to attack cancer from multiple biological angles:

• Fenbendazole (222 mg daily): Acts on cancer cell microtubules, interfering with glucose transport and disrupting cell division without harming normal cellular structure.
• Bioavailable Curcumin (600 mg daily): A natural polyphenol that downregulates NF-kB, one of the primary genetic master switches driving chronic inflammation and tumor growth.
• Full-Spectrum CBD Oil (25 mg daily): Supports the endocannabinoid system, reduces systemic inflammation, relieves pain, and improves sleep depth.
• Tocotrienols & Tocopherols (Vitamin E): High-potency lipid-soluble antioxidants that protect normal cellular membranes from oxidative damage.

The Clinical Miracle: Total PET Scan Clearance

In May 2017, three months after starting his combined approach alongside the Keytruda trial, Joe returned to MD Anderson for a follow-up PET scan. When the oncologist walked into the exam room, he was speechless. The scan was completely dark: every single metastatic tumor in his neck, liver, pancreas, bladder, and bones had completely disappeared.

Of all the patients enrolled in that specific Phase 1 clinical trial, Joe was the only individual whose cancer had completely vanished. Today, over eight years after being told he had weeks to live, Joe continues to live an active, full life with zero evidence of disease.

Key Takeaways for Us and for You

When Dr. Jean and I review Joe’s story, three key lessons stand out for every cancer warrior:

1. Modern medicine and terrain support work best together: The internet often argues whether it was Keytruda or Fenbendazole that healed Joe. We believe it was the synergy of both: immunotherapy provided the spark, and metabolic support cleared the battlefield.
2. Never accept an expiration date: Doctors give statistical averages based on historical populations, but you are not a statistic. You are an individual with unique biology, faith, and willpower.
3. Transparency creates hope: Joe chose to share his story openly on his blog without charging money for his knowledge, inspiring hundreds of thousands of patients to research complementary pathways.